Applications for global Cryoimmunostaining™ technology trial now open Bangkok, July 2018 – After successfully completing a series of clinical trials across Southeast Asia, atypical cell detection specialist X-ZELL is now making the company’s patented...
X-ZELL CEO to present at Asia-Pacific Prostate Cancer Conference Brisbane, July 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, will use the upcoming Asia-Pacific Prostate Cancer Conference (APCC) in Brisbane next month as a platform to reveal “exciting new insights” into...
